NEXUS AG (NXU.DE) Stock Fundamental Analysis

FRA:NXU • DE0005220909

71.2 EUR
-0.1 (-0.14%)
Last: Nov 24, 2025, 07:00 PM
Fundamental Rating

7

Overall NXU gets a fundamental rating of 7 out of 10. We evaluated NXU against 11 industry peers in the Health Care Technology industry. NXU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NXU is valued quite expensive, but it does show an excellent growth. These ratings could make NXU a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year NXU was profitable.
  • In the past year NXU had a positive cash flow from operations.
  • In the past 5 years NXU has always been profitable.
  • NXU had a positive operating cash flow in each of the past 5 years.
NXU.DE Yearly Net Income VS EBIT VS OCF VS FCFNXU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • NXU has a Return On Assets (6.93%) which is in line with its industry peers.
  • NXU has a better Return On Equity (11.27%) than 63.64% of its industry peers.
  • NXU's Return On Invested Capital of 8.35% is in line compared to the rest of the industry. NXU outperforms 54.55% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NXU is in line with the industry average of 8.41%.
  • The last Return On Invested Capital (8.35%) for NXU is above the 3 year average (7.85%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.93%
ROE 11.27%
ROIC 8.35%
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
NXU.DE Yearly ROA, ROE, ROICNXU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • The Profit Margin of NXU (12.11%) is better than 72.73% of its industry peers.
  • NXU's Profit Margin has improved in the last couple of years.
  • The Operating Margin of NXU (15.41%) is better than 72.73% of its industry peers.
  • NXU's Operating Margin has improved in the last couple of years.
  • NXU has a Gross Margin of 84.70%. This is in the better half of the industry: NXU outperforms 72.73% of its industry peers.
  • In the last couple of years the Gross Margin of NXU has remained more or less at the same level.
Industry RankSector Rank
OM 15.41%
PM (TTM) 12.11%
GM 84.7%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
NXU.DE Yearly Profit, Operating, Gross MarginsNXU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NXU is creating some value.
  • NXU has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NXU has been increased compared to 5 years ago.
  • Compared to 1 year ago, NXU has an improved debt to assets ratio.
NXU.DE Yearly Shares OutstandingNXU.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NXU.DE Yearly Total Debt VS Total AssetsNXU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 5.57 indicates that NXU is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.57, NXU belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • The Debt to FCF ratio of NXU is 0.34, which is an excellent value as it means it would take NXU, only 0.34 years of fcf income to pay off all of its debts.
  • NXU has a Debt to FCF ratio of 0.34. This is in the better half of the industry: NXU outperforms 72.73% of its industry peers.
  • A Debt/Equity ratio of 0.05 indicates that NXU is not too dependend on debt financing.
  • NXU has a better Debt to Equity ratio (0.05) than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.34
Altman-Z 5.57
ROIC/WACC1.16
WACC7.21%
NXU.DE Yearly LT Debt VS Equity VS FCFNXU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

  • NXU has a Current Ratio of 2.13. This indicates that NXU is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.13, NXU is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • A Quick Ratio of 2.08 indicates that NXU has no problem at all paying its short term obligations.
  • NXU has a better Quick ratio (2.08) than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.08
NXU.DE Yearly Current Assets VS Current LiabilitesNXU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

7

3. Growth

3.1 Past

  • NXU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.97%, which is quite impressive.
  • The Earnings Per Share has been growing by 20.97% on average over the past years. This is a very strong growth
  • NXU shows a small growth in Revenue. In the last year, the Revenue has grown by 7.41%.
  • NXU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.11% yearly.
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%

3.2 Future

  • Based on estimates for the next years, NXU will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.50% on average per year.
  • NXU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.47% yearly.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NXU.DE Yearly Revenue VS EstimatesNXU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
NXU.DE Yearly EPS VS EstimatesNXU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 36.14, which means the current valuation is very expensive for NXU.
  • NXU's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.64. NXU is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 32.24, which means the current valuation is very expensive for NXU.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NXU is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 27.75. NXU is around the same levels.
Industry RankSector Rank
PE 36.14
Fwd PE 32.24
NXU.DE Price Earnings VS Forward Price EarningsNXU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 63.64% of the companies in the same industry are cheaper than NXU, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, NXU is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.76
EV/EBITDA 16.21
NXU.DE Per share dataNXU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of NXU may justify a higher PE ratio.
  • NXU's earnings are expected to grow with 15.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.48
PEG (5Y)1.72
EPS Next 2Y14.95%
EPS Next 3Y15.5%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.32%, NXU is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.32, NXU has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.32, NXU pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
NXU.DE Yearly Dividends per shareNXU.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 11.69% of the earnings are spent on dividend by NXU. This is a low number and sustainable payout ratio.
  • The dividend of NXU is growing, but earnings are growing more, so the dividend growth is sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
NXU.DE Yearly Income VS Free CF VS DividendNXU.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NXU.DE Dividend Payout.NXU.DE Dividend Payout, showing the Payout Ratio.NXU.DE Dividend Payout.PayoutRetained Earnings

NEXUS AG

FRA:NXU (11/24/2025, 7:00:00 PM)

71.2

-0.1 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-04
Earnings (Next)03-02
Inst Owners21.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.23B
Revenue(TTM)280.33M
Net Income(TTM)33.95M
Analysts45.71
Price Target71.4 (0.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 36.14
Fwd PE 32.24
P/S 4.39
P/FCF 21.76
P/OCF 18.33
P/B 4.08
P/tB 17.79
EV/EBITDA 16.21
EPS(TTM)1.97
EY2.77%
EPS(NY)2.21
Fwd EY3.1%
FCF(TTM)3.27
FCFY4.59%
OCF(TTM)3.88
OCFY5.46%
SpS16.23
BVpS17.45
TBVpS4
PEG (NY)2.48
PEG (5Y)1.72
Graham Number27.81
Profitability
Industry RankSector Rank
ROA 6.93%
ROE 11.27%
ROCE 11.14%
ROIC 8.35%
ROICexc 12.84%
ROICexgc 162.09%
OM 15.41%
PM (TTM) 12.11%
GM 84.7%
FCFM 20.15%
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexgc growth 3Y-0.23%
ROICexgc growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.34
Debt/EBITDA 0.22
Cap/Depr 53.69%
Cap/Sales 3.78%
Interest Coverage 250
Cash Conversion 106.6%
Profit Quality 166.39%
Current Ratio 2.13
Quick Ratio 2.08
Altman-Z 5.57
F-Score6
WACC7.21%
ROIC/WACC1.16
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y16.23%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y141.55%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y109.22%
OCF growth 3Y17.98%
OCF growth 5Y15.93%

NEXUS AG / NXU.DE FAQ

Can you provide the ChartMill fundamental rating for NEXUS AG?

ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE.


What is the valuation status for NXU stock?

ChartMill assigns a valuation rating of 3 / 10 to NEXUS AG (NXU.DE). This can be considered as Overvalued.


Can you provide the profitability details for NEXUS AG?

NEXUS AG (NXU.DE) has a profitability rating of 7 / 10.


How financially healthy is NEXUS AG?

The financial health rating of NEXUS AG (NXU.DE) is 8 / 10.


What is the expected EPS growth for NEXUS AG (NXU.DE) stock?

The Earnings per Share (EPS) of NEXUS AG (NXU.DE) is expected to grow by 14.6% in the next year.